QuantX Labs
company
Quantx, a biotech firm focused on oral immunology, announced a $85 million financing round to advance its drug candidates. The new capital will fund preclinical and early clinical development, expanding its pipeline in the immunology space.
Want to join the conversation?
Loading comments...
Comments
Want to join the conversation?
Loading comments...